Artificial Intelligence Approaches for Predicting the Risks of Durable Mechanical Circulatory Support Therapy and Cardiac Transplantation

Abstract

Background: The use of AI-driven technologies in probing big data to generate better risk prediction models has been an ongoing and expanding area of investigation. The AI-driven models may perform better as compared to linear models; however, more investigations are needed in this area to refine their predictability and applicability to the field of durable MCS and cardiac transplantation. Methods: A literature review was carried out using Google Scholar/PubMed from 2000 to 2023. Results: This review defines the knowledge gaps and describes different AI-driven approaches that may be used to further our understanding. Conclusions: The limitations of current models are due to missing data, data imbalances, and the uneven distribution of variables in the datasets from which the models are derived. There is an urgent need for predictive models that can integrate a large number of clinical variables from multicenter data to account for the variability in patient characteristics that influence patient selection, outcomes, and survival for both durable MCS and HT; this may be fulfilled by AI-driven risk prediction models.

Unveiling the future of cardiac care: advances in mechanical circulatory support

“…Artificial intelligence (AI) has become a valuable tool in cardiovascular medicine, particularly in predicting outcomes for patients undergoing durable mechanical circulatory support (MCS) and heart transplantation (HT) for end-stage heart failure [73]. The integration and analysis of complex clinical data using AI have shown promise in improving risk prediction and optimizing patient selection for these therapies [74], [75], [76], [77], [78].…”